Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

BRD4 inhibitor GNE987 exerts anti-cancer effects by targeting super-enhancers in neuroblastoma
Yanling Chen, Xiaolu Li, Gen Li, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 16

Showing 16 citing articles:

BRD4: New hope in the battle against glioblastoma
Weichen Duan, Miao Yu, Jiajia Chen
Pharmacological Research (2023) Vol. 191, pp. 106767-106767
Open Access | Times Cited: 18
Selective degradation of BRD4 suppresses lung cancer cell proliferation using GSH-responsive PROTAC precursors
Heli Fan, Zhili Zhou, Dehao Yu, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106793-106793
Closed Access | Times Cited: 15
Fam163a knockdown and mitochondrial stress in the arcuate nucleus of hypothalamus reduce AgRP neuron activity and differentially regulate mitochondrial dynamics in mice
Cihan Süleyman Erdogan, Yavuz Yavuz, Hüseyin Buğra Özgün, et al.
Acta Physiologica (2025) Vol. 241, Iss. 4
Open Access
The role of FOXO4/NFAT2 signaling pathway in dysfunction of human coronary endothelial cells and inflammatory infiltration of vasculitis in Kawasaki disease
Hongbiao Huang, Jinfeng Dong, Jiaqi Jiang, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 10
Eltrombopag Inhibited Liver Cancer by Enhancing SMYD4 Protein Degradationvia TRIP12 Ubiquitinase
Jiale Li, Qiqiang Zhang, Chunyan Wang, et al.
Advanced Therapeutics (2025)
Closed Access
The BET inhibitor GNE-987 effectively induces anti-cancer effects in T-cell acute lymphoblastic leukemia by targeting enhancer regulated genes
Juanjuan Yu, Yang Yang, Rongfang Zhou, et al.
Carcinogenesis (2024) Vol. 45, Iss. 6, pp. 424-435
Closed Access | Times Cited: 2
STAT3 drives the expression of HIF1alpha in cancer cells through a novel super-enhancer
Yonghui Dai, Ying Yue, Gaoyang Zhu, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 735, pp. 150483-150483
Closed Access | Times Cited: 1
Super‐Enhancer‐Driven IRF2BP2 is Activated by Master Transcription Factors and Sustains T‐ALL Cell Growth and Survival
Juanjuan Yu, Zimu Zhang, Yanling Chen, et al.
Advanced Science (2024)
Open Access | Times Cited: 1
An inhibitor of BRD4, GNE987, inhibits the growth of glioblastoma cells by targeting C-Myc and S100A16
Liya Ma, Gen Li, Tianquan Yang, et al.
Cancer Chemotherapy and Pharmacology (2022) Vol. 90, Iss. 6, pp. 431-444
Open Access | Times Cited: 7
MZ1, a BRD4 inhibitor, exerted its anti-cancer effects by suppressing SDC1 in glioblastoma
Gen Li, Liya Ma, Chenxi Feng, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Review on: BRD4 inhibitors for anticancer research
Vindhya Vikram Singh, Shafqat Alauddin
Human Gene (2023) Vol. 37, pp. 201196-201196
Closed Access | Times Cited: 3
Crystal structure of [1,2,4]triazolo[4,3-b]pyridazine derivatives as BRD4 bromodomain inhibitors and structure–activity relationship study
Jung‐Hoon Kim, Navin Pandit, Miyoun Yoo, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
The potential of BRD4 inhibition in tumour mechanosignaling
Antonios N. Gargalionis, Kostas A. Papavassiliou, Athanasios G. Papavassiliou
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 24, pp. 4215-4218
Open Access | Times Cited: 2
The BET PROTAC inhibitor GNE-987 displays anti-tumor effects by targeting super-enhancers regulated gene in osteosarcoma
Di Wu, Hongli Yin, Chun Yang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
Histone methylation modification patterns and relevant M-RiskScore in acute myeloid leukemia
Dade Rong, Xiaohong Chen, Jing Xiao, et al.
Heliyon (2022) Vol. 8, Iss. 9, pp. e10610-e10610
Open Access | Times Cited: 2
Super-enhancers in esophageal carcinoma: Transcriptional addictions and therapeutic strategies
Yang Shi, Meiqi Wang, Dan Liu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 1
Page 1

Scroll to top